The effects of lead on antioxidants enzymes in children and the therapeutic/prophylactic role of antioxidants;Kurşunun çocuklardaki antioksidan enzimler üzerine etkileri ve antioksidanlarin tedavi edici/koruyucu rolü

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 53, Issue 2, 2010, Pages 159-173

  Çaylak, Emrah ^a   Halifeoǧlu, Ihsan ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Children; Lead; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAPTOPRIL; EDETATE CALCIUM; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; LEAD; METHIONINE; PENICILLAMINE; PYRIDOXINE; S ADENOSYLMETHIONINE; SELENIUM; SUCCIMER; TAURINE; THIOCTIC ACID; THIOL PROTEINASE; TRACE ELEMENT; WATER;

BEHAVIOR DISORDER; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CHELATION; CHILD; COGNITIVE DEFECT; GROWTH INHIBITION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LEAD POISONING; NERVOUS SYSTEM INJURY; NEUROTOXICITY; OXIDATIVE STRESS; REVIEW;

EID: 77953298573     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Kaya S, Akar F. Metaller ve diǧer inorganik ve radyoetkin maddeler. İçinde: Kaya S, Pirinçci İ, Bilgili A (ed). Veteriner Hekimliǧinde Toksikoloji (İkinci baski). Ankara: Medisan Yayinlari, 1998: 134-138.
2. Philip AT, Gerson B. Lead poisoning-Part I. Incidence, etiology, and toxicokinetics. Clin Lab Med 1994; 14: 423-444.
3. Ziegler EE, Edwards BB, Jensen RL, Mahaffey KR, Fomon SJ. Absorption and retention of lead by infants. Pediatr Res 1978; 12: 29-34.
4. Bogden JD, Gertner SB, Christakos S, et al. Dietary calcium modifies concentrations of lead and other metals and renal calbindin in rats. J Nutr 1992; 122: 1351-1360.
5. Barltrop D, Khoo HE. The influence of nutritional factors on lead absorption. Postgrad Med J 1975; 51: 795-800.
6. Markowitz M. Lead poisoning. Pediatr Rev 2000; 21: 327-335.
7. Papanikolaou NC, Hatzidaki EG, Belivanis S, Tzanakakis GN, Tsatsakis AM. Lead toxicity update. A brief review. Med Sci Monit 2005; 11: RA329-336.
8. Rabinowitz MB, Wetherill GW, Kopple JD. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 1976; 58: 260-270.
9. Wittmers LE, Jr, Aufderheide AC, Wallgren J, Rapp G Jr, Alich A. Lead in bone. IV. Distribution of lead in the human skeleton. Arch Environ Health 1988; 43: 381-391.
10. Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology 2002; 180: 33-44.
11. Kalia K, Flora SJ. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health 2005; 47: 1-21.
12. Solliway BM, Schaffer A, Pratt H, Yannai S. Effects of exposure to lead on selected biochemical and haematological variables. Pharmacol Toxicol 1996; 78: 18-22.
13. WHO. Environmental Health Criteria 165-Inorganic lead. Geneva: 1995.
14. Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit 2006; 12: RA57-65.
15. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res 1999; 24: 595-600.
16. Pollock CA, Ibels LS. Lead nephropathy-a preventable cause of renal failure. Int J Artif Organs 1988; 11: 75-78.
17. de Burbure C, Buchet JP, Leroyer A, et al. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 2006; 114: 584-590.
18. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997; 105: 928-938.
19. Fanning D. A mortality study of lead workers, 1926-1985. Arch Environ Health 1988; 43: 247-251.
20. Lin JL, Lin-Tan DT, Yen TH, et al. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis. Am J Kidney Dis 2008; 51: 107-115.
21. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 2006; 114: 1538-1541.
22. Staessen JA, Bulpitt CJ, Fagard R, et al. Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk 1994; 1: 87-97.
23. Ding Y, Gonick HC, Vaziri ND. Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens 2000; 13: 552-555.
24. Grandjean P. Health significance of metals- lead. Maxcy-Rosenau-Last Public Health and Preventive Medicine 1992; 389-391.
25. Rousseau MC, Straif K, Siemiatycki J. IARC carcinogen update. Environ Health Perspect 2005; 113: A580-581.
26. Fu H, Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med 1995; 52: 73-81.
27. Petrone LR. Iron deficiency, lead poisoning, and development. Arch Pediatr Adolesc Med 2007; 161: 523; author reply 523-524.
28. Elevated Lead in D.C. Drinking Water-A Study of Potential Causative Events, Final Summary Report; EPA-815-R-07-021, 2008.
29. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001; 1: 529-539.
30. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000; 29: 927-945.
31. Machartova V, Racek J, Kohout J, Senft V, Trefil L. [Effect of antioxidant therapy on indicators of free radical activity in workers at risk of lead exposure]. Vnitr Lek 2000; 46: 444-446.
32. Warren MJ, Cooper JB, Wood SP, Shoolingin-Jordan PM. Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem Sci 1998; 23: 217-221.
33. Philip AT, Gerson B. Lead poisoning-Part II. Effects and assay. Clin Lab Med 1994; 14: 651-670.
34. Somashekaraiah BV, Venkaiah B, Prasad AR. Biochemical diagnosis of occupational exposure to lead toxicity. Bull Environ Contam Toxicol 1990; 44: 268-275.
35. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for lead (Draft for Public Comment). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2005: 63.
36. Paglia DE, Valentine WN, Fink K. Lead poisoning. Further observations on erythrocyte pyrimidinenucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides. J Clin Invest 1977; 60: 1362-1366.
37. Mahaffey KR, Rosen JF, Chesney RW, et al. Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr 1982; 35: 1327-1331.
38. Rosen JF, Chesney RW, Hamstra A, DeLuca HF, Mahaffey KR. Reduction in 1,25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med 1980; 302: 1128-1131.
39. Costa CA, Trivelato GC, Pinto AM, Bechara EJ. Correlation between plasma 5-aminolevulinic acid concentrations and indicators of oxidative stress in lead-exposed workers. Clin Chem 1997; 43: 1196-1202.
40. Fujita H, Sato K, Sano S. Increase in the amount of erythrocyte delta-aminolevulinic acid dehydratase in workers with moderate lead exposure. Int Arch Occup Environ Health 1982; 50: 287-297.
41. Fujita H. Measurement of ALA dehydratase activity. In: Maines M, Costa LG, Hodgson E, Reed DJ, Sipes IG (eds). Current Protocols in Toxicology. New York: John Wiley & Sons, 1999: 1-11.
42. Fujita H, Orii Y, Sano S. Evidence of increased synthesis of delta-aminolevulinic acid dehydratase in experimental lead-poisoned rats. Biochim Biophys Acta 1981; 678: 39-50.
43. Fujita H, Ishihara N. Evidence of the induction of de novo synthesis of delta-aminolaevulinate dehydratase by lead. Br J Ind Med 1988; 45: 710-712.
44. Lachant NA, Tomoda A, Tanaka KR. Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning. Blood 1984; 63: 518-524.
45. Calderon-Salinas V, Hernandez-Luna C, Maldonado M, Saenz D. Mechanisms of the toxic effect of lead. I. Free lead in erythrocyte. J Expo Anal Environ Epidemiol 1993; 3 (Suppl): 153-164.
46. Rogers LE, Battles ND, Reimold EW, Sartain P. Erythrocyte enzymes in experimental lead poisoning. Arch Toxikol 1971; 28: 202-207.
47. McIntire MS, Angle CR. Air lead: relation to lead in blood of black school children deficient in glucose-6-phosphate dehydrogenase. Science 1972; 177: 520-522.
48. Parcell S. Sulfur in human nutrition and applications in medicine. Altern Med Rev 2002; 7: 22-44.
49. Hsu JM. Lead toxicity as related to glutathione metabolism. J Nutr 1981; 111: 26-33.
50. Ahamed M, Verma S, Kumar A, Siddiqui MK. Environmental exposure to lead and its correlation with biochemical indices in children. Sci Total Environ 2005; 346: 48-55.
51. Hunaiti AA, Soud M. Effect of lead concentration on the level of glutathione, glutathione S-transferase, reductase and peroxidase in human blood. Sci Total Environ 2000; 248: 45-50.
52. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-186.
53. Rinaldi R, Eliasson E, Swedmark S, Morgenstern R. Reactive intermediates and the dynamics of glutathione transferases. Drug Metab Dispos 2002; 30: 1053-1058.
54. Kasperczyk S, Kasperczyk J, Ostalowska A, et al. The role of the antioxidant enzymes in erythrocytes in the development of arterial hypertension among humans exposed to lead. Biol Trace Elem Res 2009; 130: 95-106.
55. Dock L. Induction of rat liver glutathione transferase isoenzyme 7-7 by lead nitrate. Biol Trace Elem Res 1989; 21: 283-288.
56. Suzuki YJ, Tsuchiya M, Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic Res Commun 1993; 18: 115-122.
57. Mousa HM, Al-Qarawi AA, Ali BH, Abdel Rahman HA, ElMougy SA. Effect of lead exposure on the erythrocytic antioxidant levels in goats. J Vet Med A Physiol Pathol Clin Med 2002; 49: 531-534.
58. Sivaprasad R, Nagaraj M, Varalakshmi P. Combined efficacies of lipoic acid and 2,3-dimercaptosuccinic acid against lead-induced lipid peroxidation in rat liver. J Nutr Biochem 2004; 15: 18-23.
59. Caylak E, Aytekin M, Halifeoglu I. Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Exp Toxicol Pathol 2008; 60: 289-294.
60. Monteiro HP, Abdalla DS, Arcuri AS, Bechara EJ. Oxygen toxicity related to exposure to lead. Clin Chem 1985; 31: 1673-1676.
61. Kasperczyk S, Kasperczyk A, Ostalowska A, Dziwisz M, Birkner E. Activity of glutathione peroxidase, glutathione reductase, and lipid peroxidation in erythrocytes in workers exposed to lead. Biol Trace Elem Res 2004; 102: 61-72.
62. Çaylak E, Halifeoǧlu İ. Sülfür içeren antioksidanlarin kurşuna maruz kalmiş ratlarda karaciǧer, böbrek ve beyin MDA ve katalaz düzeylerine antioksidan etkileri. Türkiye Klinikleri J Med Sci 2007; 27: 1-8.
63. Devi SS, Biswas AR, Biswas RA, et al. Heavy metal status and oxidative stress in diesel engine tuning workers of central Indian population. J Occup Environ Med 2007; 49: 1228-1234.
64. Mayes P. Abiologic oxidation. In: Murray RK, Granner DK, Mayes PA, Rodwell VW (eds). Harper's Biochemistry (25th ed). Stamford: Appleton & Lange, 2000: 130-137.
65. Tandon SK, Flora SJ, Singh S. Influence of pyridoxine (vitamin B6) on lead intoxication in rats. Ind Health 1987; 25: 93-96.
66. McGowan C. Influence of vitamin B6 status on aspects of lead poisoning in rats. Toxicol Lett 1989; 47: 87-93.
67. Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990; 8: 281-291.
68. Levander OA, Morris VC, Ferretti RJ. Filterability of erythrocytes from vitamin E-deficient lead-poisoned rats. J Nutr 1977; 107: 363-372.
69. Dhawan M, Flora SJ, Tandon SK. Preventive and therapeutic role of vitamin E in chronic plumbism. Biomed Environ Sci 1989; 2: 335-340.
70. Dhawan M, Kachru DN, Tandon SK. Influence of thiamine and ascorbic acid supplementation on the antidotal efficacy of thiol chelators in experimental lead intoxication. Arch Toxicol 1988; 62: 301-304.
71. Simon JA, Hudes ES. Relationship of ascorbic acid to blood lead levels. JAMA 1999; 281: 2289-2293.
72. Othman AI, El Missiry MA. Role of selenium against lead toxicity in male rats. J Biochem Mol Toxicol 1998; 12: 345-349.
73. Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 2004; 45: 776-788.
74. Flora GJ, Seth PK. Beneficial effects of S-adenosyl-L-methionine on aminolevulinic acid dehydratase, glutathione, and lipid peroxidation during acute lead-ethanol administration in mice. Alcohol 1999; 18: 103-108.
75. Ercal N, Treeratphan P, Lutz P, Hammond TC, Matthews RH. N-actylcysteine protects Chinese hamster ovary (CHO) cells from lead-induced oxidative stress. Toxicology 1996; 108: 57-64.
76. Ercal N, Treeratphan P, Hammond TC, et al. In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radic Biol Med 1996; 21: 157-161.
77. Gurer H, Ozgunes H, Neal R, Spitz DR, Ercal N. Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 1998; 128: 181-189.
78. Çaylak E, Halifeoǧlu İ. Sülfür içeren antioksidanlann kurşuna maruz kalmiş ratlarda karaciǧer, böbrek ve beyin MDA ve katalaz düzeylerine antioksidan etkileri. Türkiye Klinikleri J Med Sci 2007; 27: 1-8.
79. Caylak E, Halifeoglu I, Aydin S, Telo S, Bulmus O, Celik H. The effects of sulfur-containing compounds on total antioxidant capacity levels of liver, kidney and brain in lead-exposed rats. Tiirkiye Klinikleri J Med Sci 2007; 27: 823-828.
80. Stadtman ER, Van Remmen H, Richardson A, Wehr NB, Levine RL. Methionine oxidation and aging. Biochim Biophys Acta 2005; 1703: 135-140.
81. Patra RC, Swamp D, Dwivedi SK. Antioxidant effects of alpha tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 2001; 162: 81-88.
82. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250.
83. Moini H, Packer L, Saris NE. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 2002; 182: 84-90.
84. Gurer H, Ozgunes H, Oztezcan S, Ercal N. Antioxidant role of alpha-lipoic acid in lead toxicity. Free Radic Biol Med 1999; 27: 75-81.
85. Gurer H, Neal R, Yang P, Oztezcan S, Ercal N. Captopril as an antioxidant in lead-exposed Fischer 344 rats. Hum Exp Toxicol 1999; 18: 27-32.
86. Gurer H, Ozgunes H, Saygin E, Ercal N. Antioxidant effect of taurine against lead-induced oxidative stress. Arch Environ Contam Toxicol 2001; 41: 397-402.
87. Finkelstein JD, Martin JJ. Homocysteine. IntJ Biochem Cell Biol 2000; 32: 385-389.
88. Zappacosta B, Mordente A, Persichilli S, Giardina B, De Sole P. Effect of homocysteine on polymorphonuclear leukocyte activity and luminol-dependent chemiluminescence. Luminescence 2000; 15: 257-260.
89. Zappacosta B, Mordente A, Persichilli S, et al. Is homocysteine a pro-oxidant? Free Radic Res 2001; 35: 499-505.
90. Kang AH, Trelstad RL. A collagen defect in homocystinuria. J Clin Invest 1973; 52: 2571-2578.
91. Zhou J, Moller J, Danielsen CC, et al. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 1470-1476.